Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome.
Inhibition of MMP-1 expression by antisense RNA decreases invasiveness of human chondrosarcoma.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome.
Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome. Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 05; 147B(7):1253-7.
View in:
PubMed
subject areas
Animals
Biomarkers
Extracellular Signal-Regulated MAP Kinases
Fragile X Mental Retardation Protein
Fragile X Syndrome
Humans
Lymphocytes
Mice
Mice, Knockout
Neurons
Phosphorylation
Thymus Gland
Time Factors
authors with profiles
Elizabeth Berry-Kravis